An Italian life sciences company is planning to establish its new U.S. hub in central Indiana. Stevanato Group with a $145 million investment to build and equip a 370,000-square-foot manufacturing facility in Fishers and create more than 230 jobs by the end of 2025.
The company, which provides drug containment, drug delivery and diagnostic services for the pharmaceutical, biotechnology and life sciences industries, says the facility will support the expansion and production of its EZ-Fill solutions.

Construction of the facility is expected to begin later this year. Stevanato Group says the facility will include state-of-the-art production lines to manufacture its EZ-Fill syringes and vials for pharmaceutical companies. It will also include office space and an after-sales support center to serve U.S. engineering customers.

"Central Indiana is well positioned to support exponential growth in the life sciences and advanced manufacturing industries," Fishers Mayor Scott Fadness said in a press release. "As we continue to see an emerging life sciences cluster here in Fishers, we believe Stevanato Group's decision to invest in Fishers underscores the opportunity for growth."

The facility is expected to be operational in 2023. The company plans to hire for a variety of positions, including manufacturing, engineering, maintenance and other business support jobs, at a later date.

Stevanato Group employs about 4,300 people worldwide and also has U.S. locations in California, Pennsylvania and Massachusetts.

The Indiana Economic Development Corp. has offered Stevanato Group up to $3.4 million in conditional tax credits and training grants, which the company cannot apply for until Hoosier workers are hired for the new jobs. The city of Fishers will also consider up to $1.2 million in additional incentives.

Source: www.insideindianabusiness.com